News and Trends 9 Jun 2025 First antibiotic in 50 years to tackle superbug nears approval: what’s going on in the field? Antibiotic development has seen a slump in recent decades. Now, after 50 years, a new antibiotic has been created to tackle bacterial infections. June 9, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 19 May 2025 Will Europe become the new home for US researchers affected by policy shifts? The European Union has launched the Choose Europe for Science initiative and pledged €500 million in funding in a move to attract U.S. researchers. May 19, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 28 Apr 2025 U.S. budget cuts: what is the impact on therapeutic research? We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs and lawsuits. April 28, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 19 Feb 2025 Trade war: how new U.S. tariffs will impact the biopharma industry The U.S. plans to impose trade tariffs on imports. How does this affect the biopharma industry? February 19, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 13 Dec 2024 Is China the future of biotech? Delve into the ongoing transformation of China’s biotech industry in the last 10 years and in the future evolving geopolitical context. December 13, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 7 Mar 2024 Can AbbVie’s legacy live beyond its once best-selling drug Humira? The sales of AbbVie’s Humira, once a best-seller, have dropped. Now, with a new CEO announced, things are about to change for the company. March 7, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Expert Advice 1 Feb 2024 Corporate Sustainability Reporting Directive: Is the life sciences industry ready? 2024 will be the first year when biotechs will have to report on their sustainability data under the CSRD. But is the industry prepared? February 1, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 27 Nov 2023 How are R&D Tax Incentives shaping Australia’s biotech future? Research and development (R&D) stands as a cornerstone for driving innovation, particularly within the biotech industry. The pivotal role of R&D extends beyond immediate commercial implications and encompasses a broader spectrum of societal and economic benefits. R&D represents significant expense, and if big companies can afford the risk, it may not be the case for […] November 27, 2023 - 5 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 25 Oct 2021 Biotech Startups Face a Growing Wave of Cyberattacks The onset of the Covid-19 pandemic last year triggered a wave of cyberattacks in the life sciences industry, and the problem is likely to get worse. Biotech startups need to improve their cybersecurity, but where should they start? In January 2020, it was time to open the champagne for Andrew Sewell, Professor of Infection and […] October 25, 2021 - 11 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 3 Feb 2021 Detecting Gene-Edited Food: The EU’s Nightmare The EU imposed stringent controls on the commercialization of gene-edited food back in 2018. Years later, regulators are still working in the dark, with no established tests in place. The EU has some of the strictest food regulations in the world surrounding the cultivation and commercialization of genetically modified organisms (GMOs), which it defines as organisms whose […] February 3, 2021 - 10 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 7 Dec 2020 Are We Still Friends? What Brexit Means for UK Synthetic Biology Synthetic biology is one of the big strengths of UK science, but can the country uphold its vantage point after Brexit, without the support of the EU? (Disclaimer: At the time of writing, no deal has been made between the UK and the EU following Brexit. This intrepid writer is an Irish citizen who made […] December 7, 2020 - 8 minutesmins - By David Kirk Share WhatsApp Twitter Linkedin Email
News and Trends 4 Dec 2020 EU Launches Pharma Strategy, Raising Both Hopes and Questions The public’s response has been cautious after the European Union unveiled a pharmaceutical strategy last week designed to spur domestic innovation and the production of affordable, state-of-the-art therapies. Amid a boom in biotech funding driven by the Covid-19 pandemic, the European Commission (EC) is scrambling to bring its sometimes fragmented pharma regulatory framework up to […] December 4, 2020 - 6 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email